Table 2.
Clinical characteristics of ovarian cancer survivors
| Ovarian cancer survivors (N=1270) |
||
|---|---|---|
| N | % | |
| Year of diagnosis | ||
| 1996–2000 | 341 | 26.9% |
| 2001–2005 | 372 | 29.3% |
| 2006–2012 | 557 | 43.9% |
| Age at diagnosis | ||
| 18–49 | 346 | 27.2% |
| 50–59 | 323 | 25.4% |
| 60–69 | 286 | 22.5% |
| 70–79 | 243 | 19.1% |
| 80–93 | 72 | 5.7% |
| Stage | ||
| Localized | 282 | 22.2% |
| Regional | 219 | 17.2% |
| Distant | 769 | 60.6% |
| Treatment | ||
| Surgery only | 333 | 26.2% |
| Surgery and chemotherapy | 800 | 63.0% |
| Other treatmenta | 88 | 6.9% |
| Missing | 49 | 3.9% |
| Surgery typeb | ||
| Limited surgery | 194 | 17.0% |
| Aggressive surgery | 947 | 83.0% |
| Histology | ||
| High-grade serous | 714 | 56.2% |
| Low-grade serous | 15 | 1.2% |
| Endometrioid | 136 | 10.7% |
| Mucinous | 88 | 6.9% |
| Clear Cell | 75 | 5.9% |
| Carcinosarcoma | 17 | 1.3% |
| Carcinoma, NOS | 114 | 9.0% |
| Other typec | 111 | 8.7% |
a.
Includes chemotherapy only, surgery and radiation, chemotherapy and radiation, surgery and radiation and chemotherapy.
b.
Limited surgery: removal of tumor or unilateral/bilateral oophorectomy (with or without hysterectomy). Aggressive surgery: surgery with omentectomy, debulking, pelvic exenteration. Total N=1141.
c.
Malignant Brenner, mixed, sarcoma, non-specific